Investors Alert: Vistagen Therapeutics Faces Class Action Lawsuit Over Trial Results Vistagen Therapeutics, Inc. faces a class action lawsuit following disappointing trial results. Shareholders are urged to register before March 16, 2026.

Investors Alert: Vistagen Therapeutics Faces Class Action Lawsuit Over Trial Results #USA #New_York #Gross_Law_Firm #Vistagen #Fasedienol